Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrenceJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2023
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim AnalysisSteven G Allen, Benjamin S Rosen, Madhava Aryal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck CancerMichelle L Mierzwa, Madhava Aryal, Choonik Lee, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 25, 2021
Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing BioselectionMolly E Heft Neal, Joshua D Smith, Andrew C Birkeland, et al.
Advances in Radiation Oncology|August 21, 2025
Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx CancerSamuel Nicholas Regan, Jennifer Shah, Krithika Suresh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell CarcinomaTrisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
Head & Neck|March 18, 2023
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancerJoshua D Smith, Megan L Ludwig, Apurva D Bhangale, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2020
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapyBenjamin S Rosen, Joel R Wilkie, Yilun Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancerJoshua A Bauer, Bhavna Kumar, Kitrina G Cordell, et al.
The Journal of Molecular Diagnostics : JMD|May 7, 2026
Validation of MyHPVscore: a high-performance HPV ctDNA lab developed testJordan Currie, Heather Walline, Colleen G Hochfelder, et al.
Pageof 14